{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:13:00Z","timestamp":1791202380849,"version":"4.2.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1523,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,7]]},"abstract":"<jats:title>\n                           <jats:bold>Abstract:<\/jats:bold>\n                        <\/jats:title>\n          <jats:sec>\n            <jats:title\/>\n            <jats:p>Only 20% of patients with chronic hepatitis C (CHC) will develop cirrhosis, and fibrosis progression remains highly unpredictable. A recent genome-wide association study identified a genetic variant in the patatin-like phospholipase-3 (PNPLA3) gene (rs738409 C&gt;G) associated with steatosis that was further demonstrated to influence severity of fibrosis in nonalcoholic fatty liver disease. The aim of this study was to assess the impact of this polymorphism on histological liver damage and response to antiviral therapy in CHC. We recruited 537 Caucasian CHC patients from three European centers (Brussels, Belgium [n = 229]; Hannover, Germany [n = 171]; Lyon, France [n = 137]); these patients were centrally genotyped for the PNPLA3 (rs738409 C&gt;G) polymorphism. We studied the influence of rs738409 and other variants in the PNPLA3 region on steatosis and fibrosis assessed both in a cross-sectional and longitudinal manner. Seven other variants previously associated with fibrosis progression were included. Finally, we explored the impact of rs738409 on response to standard antiviral therapy using the interferon lambda 3 (IL28B) [rs12979860 C&gt;T] variant both as a comparator and as a positive control. After adjustment for age, sex, body mass index, alcohol consumption, and diabetes, rs738409 mutant G allele homozygote carriers remained at higher risk for steatosis (odds ratio [OR] 2.55, 95% confidence interval [CI] 1.08\u20136.03, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.034), fibrosis (OR 3.13, 95% CI 1.50\u20136.51, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.002), and fibrosis progression (OR 2.64, 95% CI 1.22\u20135.67, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.013). Conversely, rs738409 was not independently associated with treatment failure (OR 1.07, 95% CI 0.46\u20132.49, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.875) and did not influence clinical or biological variables. <jats:italic toggle=\"yes\">Conclusion:<\/jats:italic> The PNPLA3 (rs738409 C&gt;G) polymorphism favors steatosis and fibrosis progression in CHC. This polymorphism may represent a valuable genetic predictor and a potential therapeutic target in CHC liver damage. (HEPATOLOGY 2011;)<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.24350","type":"journal-article","created":{"date-parts":[[2011,4,12]],"date-time":"2011-04-12T13:23:01Z","timestamp":1302614581000},"page":"60-69","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":158,"title":["Impact of patatin-like phospholipase-3 (rs738409 C&gt;G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C"],"prefix":"10.1097","volume":"54","author":[{"given":"Eric","family":"Tr\u00e9po","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Pradat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrej","family":"Potthoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihide","family":"Momozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Quertinmont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Gustot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Lemmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Berthillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Amininejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mich\u00e9le","family":"Chevallier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Schlu\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Kreipe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Devi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Manns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Tr\u00e9po","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Sninsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiner","family":"Wedemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Franchimont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20241201","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1473-3099(05)70216-4","article-title":"Global epidemiology of hepatitis C virus infection.","volume":"5","author":"Shepard","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"R3-11-20241201","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/0091270003258669","article-title":"Global burden of disease (GBD) for hepatitis C.","volume":"44","author":"Global Burden Of Hepatitis C Working","year":"2004","journal-title":"J Clin Pharmacol"},{"key":"R4-11-20241201","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","article-title":"Natural history of liver fibrosis progression in patients with chronic hepatitis C. The The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.","volume":"349","author":"Poynard","year":"1997","journal-title":"Lancet"},{"key":"R5-11-20241201","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1053\/j.gastro.2009.09.067","article-title":"Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression.","volume":"138","author":"Davis","year":"2010","journal-title":"Gastroenterology"},{"key":"R6-11-20241201","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1053\/j.gastro.2008.02.069","article-title":"Disease progression in chronic hepatitis C: modifiable and nonmodifiable factors.","volume":"134","author":"Missiha","year":"2008","journal-title":"Gastroenterology"},{"key":"R7-11-20241201","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1053\/j.gastro.2006.03.014","article-title":"Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.","volume":"130","author":"Leandro","year":"2006","journal-title":"Gastroenterology"},{"key":"R8-11-20241201","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jhep.2009.05.016","article-title":"Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C.","volume":"51","author":"Bochud","year":"2009","journal-title":"J Hepatol"},{"key":"R9-11-20241201","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/gut.52.4.574","article-title":"Measurement and determinants of the natural history of liver fibrosis in hepatitis C virus infection: a cross sectional and longitudinal study.","volume":"52","author":"Wright","year":"2003","journal-title":"Gut"},{"key":"R10-11-20241201","first-page":"2119","article-title":"Influence of MHC class II genotype on outcome of infection with hepatitis C virus.","volume":"354","author":"Thursz","year":"1999","journal-title":"The HENCORE group Hepatitis C European Network for Cooperative Research Lancet"},{"key":"R11-11-20241201","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1365-2893.2006.00829.x","article-title":"Long-term follow-up of the hepatitis C HENCORE cohort: response to therapy and occurrence of liver-related complications.","volume":"14","author":"Pradat","year":"2007","journal-title":"J Viral Hepat"},{"key":"R12-11-20241201","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1136\/gut.2008.166348","article-title":"Gene expression and hepatitis C virus infection.","volume":"58","author":"Asselah","year":"2009","journal-title":"Gut"},{"key":"R13-11-20241201","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1053\/jhep.2003.50127","article-title":"Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal.","volume":"37","author":"Bataller","year":"2003","journal-title":"HEPATOLOGY"},{"key":"R14-11-20241201","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.21695","article-title":"A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C.","volume":"46","author":"Huang","year":"2007","journal-title":"HEPATOLOGY"},{"key":"R15-11-20241201","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/hep.23111","article-title":"A seven-gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C.","volume":"50","author":"Marcolongo","year":"2009","journal-title":"HEPATOLOGY"},{"key":"R17-11-20241201","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease.","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat Genet"},{"key":"R18-11-20241201","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/jmg.2009.066597","article-title":"A common variant in the adiponutrin gene influences liver enzyme values.","volume":"47","author":"Kollerits","year":"2010","journal-title":"J Med Genet"},{"key":"R19-11-20241201","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/hep.23622","article-title":"Homozygosity for the patatin-like phospholipase-3adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease.","volume":"51","author":"Valenti","year":"2010","journal-title":"HEPATOLOGY"},{"key":"R20-11-20241201","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/hep.23759","article-title":"The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease.","volume":"52","author":"Rotman","year":"2010","journal-title":"HEPATOLOGY"},{"key":"R21-11-20241201","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng.488","article-title":"Variant in PNPLA3 is associated with alcoholic liver disease.","volume":"42","author":"Tian","year":"2010","journal-title":"Nat Genet"},{"key":"R22-11-20241201","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/hep.24017","article-title":"Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in Caucasians.","volume":"53","author":"Stickel","year":"2011","journal-title":"HEPATOLOGY"},{"key":"R24-11-20241201","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0808010","article-title":"Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection.","volume":"361","author":"McHutchison","year":"2009","journal-title":"N Engl J Med"},{"key":"R25-11-20241201","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","article-title":"Diagnosis, management, and treatment of hepatitis C: an update.","volume":"49","author":"Ghany","year":"2009","journal-title":"HEPATOLOGY"},{"key":"R26-11-20241201","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nrg1916","article-title":"A tutorial on statistical methods for population association studies.","volume":"7","author":"Balding","year":"2006","journal-title":"Nat Rev Genet"},{"key":"R27-11-20241201","first-page":"15","article-title":"The French METAVIR Cooperative Study Group.","volume":"20","author":"Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis","year":"1994","journal-title":"HEPATOLOGY"},{"key":"R28-11-20241201","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1158\/0008-5472.CAN-08-2489","article-title":"Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors.","volume":"69","author":"Vaissiere","year":"2009","journal-title":"Cancer Res"},{"key":"R29-11-20241201","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nature09298","article-title":"Integrating common and rare genetic variation in diverse human populations.","volume":"467","author":"Altshuler","year":"2010","journal-title":"Nature"},{"key":"R30-11-20241201","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/hep.24123","article-title":"Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C.","volume":"53","author":"Valenti","year":"2011","journal-title":"HEPATOLOGY"},{"key":"R32-11-20241201","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/gepi.20533","article-title":"MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes.","volume":"34","author":"Li","year":"2010","journal-title":"Genet Epidemiol"},{"key":"R33-11-20241201","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance.","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"key":"R36-11-20241201","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1053\/j.gastro.2010.05.079","article-title":"An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic response.","volume":"139","author":"Mangia","year":"2010","journal-title":"Gastroenterology"},{"key":"R38-11-20241201","doi-asserted-by":"crossref","first-page":"7892","DOI":"10.1073\/pnas.1003585107","article-title":"A feed-forward loop amplifies nutritional regulation of PNPLA3.","volume":"107","author":"Huang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R39-11-20241201","doi-asserted-by":"crossref","first-page":"6706","DOI":"10.1074\/jbc.M109.064501","article-title":"A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis.","volume":"285","author":"He","year":"2010","journal-title":"J Biol Chem"},{"key":"R40-11-20241201","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/hep.23946","article-title":"Patatin-like phospholipase domain-containing 3 and the pathogenesis and progression of pediatric nonalcoholic fatty liver disease.","volume":"52","author":"Browning","year":"2010","journal-title":"HEPATOLOGY"},{"key":"R41-11-20241201","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/hep.20179","article-title":"Steatosis and liver cell apoptosis in chronic hepatitis C: a mechanism for increased liver injury.","volume":"39","author":"Walsh","year":"2004","journal-title":"HEPATOLOGY"},{"key":"R42-11-20241201","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1053\/j.gastro.2009.05.007","article-title":"Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial.","volume":"137","author":"Everhart","year":"2009","journal-title":"Gastroenterology"},{"key":"R43-11-20241201","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/gut.2004.050302","article-title":"Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C.","volume":"54","author":"Fartoux","year":"2005","journal-title":"Gut"},{"key":"R44-11-20241201","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.2337\/db09-0279","article-title":"Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene.","volume":"58","author":"Kantartzis","year":"2009","journal-title":"Diabetes"},{"key":"R45-11-20241201","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/ncb1631","article-title":"The lipid droplet is an important organelle for hepatitis C virus production.","volume":"9","author":"Miyanari","year":"2007","journal-title":"Nat Cell Biol"},{"key":"R46-11-20241201","doi-asserted-by":"crossref","first-page":"e1001324","DOI":"10.1371\/journal.pgen.1001324","article-title":"Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits.","volume":"7","author":"Speliotes","year":"2011","journal-title":"PLoS Genet"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.24350","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201107000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T14:01:52Z","timestamp":1733061712000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201107000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.24350","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}